Physician profile
Ashley Chan
NPI 1457764938
$4,040.41
in general payments reported to CMS, 2019-2025
32 companies · $940 in 2025
The $940 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $156 · 2022: $1,025 · 2023: $835 · 2024: $1,084 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,859.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $573.10 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $473.03 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $417.13 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $408.96 | 2021-2025 | |
| Viiv Healthcare Company | $279.37 | 2022-2025 | Apretude, Cabenuva |
| Pfizer INC. | $264.75 | 2023-2025 | |
| Novo Nordisk INC | $194.90 | 2022-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $193.35 | 2021-2025 | Pifeltro, Delstrigo, Dificid |
| Amgen INC. | $150.74 | 2022-2024 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.48 | 2022-2024 | Jardiance |
| Exact Sciences Corporation | $115.67 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Dexcom, INC. | $92.03 | 2024-2025 | Dexcom G6 Transmitter |
| Theratechnologies INC. | $90.57 | 2022-2025 | Egrifta, Trogarzo |
| Antares Pharma, INC. | $73.24 | 2022-2025 | Xyosted |
| Novartis Pharmaceuticals Corporation | $69.30 | 2022-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $58.68 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $53.17 | 2021-2023 | Eliquis |
| Kowa Pharmaceuticals America, INC. | $48.90 | 2022-2024 | Livalo |
| Abbott Laboratories | $48.00 | 2024-2025 | Freestyle Libre |
| Sanofi-Aventis U.S. LLC | $40.34 | 2022-2023 | |
| Organon LLC | $38.81 | 2022 | |
| Idorsia Pharmaceuticals US INC | $34.40 | 2023 | Quviviq |
| Edwards Lifesciences Corporation | $27.25 | 2024 | |
| Gilead Sciences, INC. | $24.02 | 2025 | |
| Vivus LLC | $22.19 | 2022 | |
| Mylan Specialty L.P. | $20.67 | 2022 | |
| Phadia US INC. | $20.33 | 2023 | Immunocap |
| Hologic Sales and Service, LLC | $19.94 | 2023 | Aptima |
| Takeda Pharmaceuticals U.S.A., INC. | $19.75 | 2021 | |
| Currax Pharmaceuticals LLC | $16.49 | 2022 | |
| Esperion Therapeutics, INC. | $16.35 | 2023 | Nexletol |
| Biohaven Pharmaceutical Holding Company LTD. | $15.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.